Filter Results:
(58)
Show Results For
- All HBS Web
(116)
- News (42)
- Research (58)
- Multimedia (1)
- Faculty Publications (35)
Show Results For
- All HBS Web
(116)
- News (42)
- Research (58)
- Multimedia (1)
- Faculty Publications (35)
←
Page 3 of 58
Results
Sort by
- 18 Oct 2016
- Op-Ed
Why Business Should Invest in Community Health
Center for Community & Population Health Improvement to facilitate the sharing of information and impact data about health improvement efforts among community stakeholders. General Dynamics subsidiary Bath Iron Works and L.L. Bean in Maine are working together to... View Details
- 01 Mar 2017
- Research & Ideas
A Good Thing Happens When Doctors Start Talking to Their Patients
recovery costs weren’t borne by the hospitals, they had not been motivated to find the low total cost alternative. After Kaplan pointed out the discrepancy, some hospitals switched to the lower-cost pre-surgical consultations. Kaplan cites View Details
- 05 Jan 2010
- First Look
First Look: January 5
there be strategic returns down the line? Purchase this case: http://cb.hbsp.harvard.edu/cb/product/710016-PDF-ENG The Joslin Diabetes Center Michael E. Porter, Elizabeth Olmsted Teisberg, and Scott WallaceHarvard Business School Case... View Details
Keywords: Martha Lagace
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
Genomic Research. Even the impetus for common diseases such as diabetes and hypertension continues to elude scientists, he said. Eric S. Lander But that will change. The major achievement that underlies biology and medicine today is that... View Details
- 24 Jan 2005
- Research & Ideas
Entrepreneurial Hospital Pioneers New Model
her own physician. Reflecting on his background, Shetty wrote on his Web site that he became a doctor because of the recurrent illnesses of his parents. As a child he lived in fear that he would lose his mother; his father, a diabetic, suffered several View Details
- 14 Jul 2006
- Op-Ed
The Case for Consumer-Driven Medicaid
diabetic and asthmatic enrollees due to increased testing and drug utilization, while management consulting firm McKinsey found that consumer-driven enrollees were more likely to "very carefully follow treatment regimens for chronic... View Details
Keywords: by Regina E. Herzlinger
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
then could be tested experimentally. Studying doctors and patients The research team devised two experiments, one involving primary care doctors, the other, patients. In the first experiment, the researchers asked physicians to evaluate hypothetical View Details
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
drug, Afrezza. MannKind would thus be the only company with an inhalable insulin on the market. As an alternative to injectable rapid-acting (or mealtime) insulin, Afrezza boasted a potential market of at least 4 million diabetic... View Details
Keywords: Sean Silverthorne
- 13 Feb 2018
- First Look
New Research and Ideas, February 13, 2018
https://cb.hbsp.harvard.edu/cbmp/product/818067-PDF-ENG Harvard Business School Case 317-105 From mHealth Hackathon to Reality: Diabetes Care This case explores the development of a business plan for a mobile health application for View Details
Keywords: Sean Silverthorne
- 05 Jan 2011
- Op-Ed
Funding Unpredictability Around Stem-Cell Research Inflicts Heavy Cost on Scientific Progress
get money. If they can't get money, they lay off people and cancel projects. Now imagine you are a postdoc in a lab and are working on a project to use human embryonic stem cells to cure diabetes by creating new beta cells in the... View Details
- 06 Apr 2015
- Research & Ideas
After Germanwings, More Attention Needed on Employee Mental Health
for fear of being accused of not being able to help themselves. "If someone has diabetes and they have to manage that chronic condition, no one bats an eyelid," says Quelch. "But if I say I have to manage a mental health problem,... View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
she adds, with the development of a vaccine against cervical cancer (Gardasil) and the launch of successful new drugs to combat diabetes and HIV/AIDS. Sato acknowledges that different situations will require different business... View Details
- 16 Jul 2008
- Op-Ed
What Should Employers Do about Health Care?
monitoring, and care for routine health issues. On-site physical therapists offer coaching to prevent injury and services to speed recovery. On-site diabetes educators work with groups of employees to engage them in lifestyle changes that... View Details
- 23 Dec 2014
- First Look
First Look: December 23
care costs. Physicians often failed to engage patients in preventative care, which many believed would help combat the rising costs of treating chronic conditions. Diabetes and hypertension, in particular, afflicted many developed nations... View Details
Keywords: Carmen Nobel
- 09 Oct 2018
- First Look
New Research and Ideas, October 9, 2018
provide focused, comprehensive care for two high-volume and expensive medical conditions: type-1 diabetes and morbid obesity. Purchase this case:https://hbsp.harvard.edu/product/718471-PDF-ENG Harvard Business School 417-023 Kurt Summers:... View Details
Keywords: Dina Gerdeman
- 05 Jun 2006
- Research & Ideas
Using Competition to Reform Healthcare
(through age twelve), adolescent (ages thirteen to twenty-two), and adult (over the age of twenty-two). Its expertise with adult patients has led to the development of a specialized reproductive practice for cystic fibrosis patients, with excellent results.5 The center... View Details
- 15 Jan 2013
- First Look
First Look: January 15
KnoopHarvard Business School Case 813-091 Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the... View Details
Keywords: Sean Silverthorne
- 07 Apr 2009
- First Look
First Look: April 7, 2009
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=109057 Amylin Pharmaceuticals: Diabetes and Beyond Harvard Business School Case 809-011 Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation... View Details
Keywords: Martha Lagace